TRAPPC2P7

Across TCGA pan-cancer cohorts, TRAPPC2P7 RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated TRAPPC2P7 data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher TRAPPC2P7 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated TRAPPC2P7 expression acts as an unfavorable survival marker.

HNSC, KIRP, and BRCA are the cancer types where TRAPPC2P7 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Tertile	III,IV	0.220	0.629	.009	117	view →
KIRP	OS	Tertile	All	0.168	0.888	<.001	90	view →
BRCA	DFS	Tertile	All	0.361	0.903	<.001	54	view →
SARC	DFS	Tertile	All	0.213	0.614	.015	21	view →
THCA	OS	Tertile	All	0.375	0.948	.015	18	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

TRAPPC2P7–HNSC (OS)

Open the HNSC breakdown →